Xiaoxia Zhang Selected Research

Linseed Oil (Flaxseed Oil)

1/2022	Dietary α-Linolenic Acid-Rich Flaxseed Oil Ameliorates High-Fat Diet-Induced Atherosclerosis via Gut Microbiota-Inflammation-Artery Axis in ApoE -/- Mice.
2/2020	Dietary flaxseed oil rich in omega-3 suppresses severity of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in rats.
1/2020	Dietary α-Linolenic Acid-Rich Flaxseed Oil Exerts Beneficial Effects on Polycystic Ovary Syndrome Through Sex Steroid Hormones-Microbiota-Inflammation Axis in Rats.
2/2017	Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoxia Zhang Research Topics

Disease

15	Neoplasms (Cancer) 04/2022 - 01/2010
10	Inflammation (Inflammations) 01/2022 - 05/2009
8	Body Weight (Weight, Body) 01/2022 - 01/2019
6	Dysbiosis 04/2022 - 01/2019
6	Infections 01/2022 - 06/2010
5	Metabolic Diseases (Metabolic Disease) 01/2022 - 10/2019
3	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2020
3	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2020 - 02/2017
3	Pain (Aches) 01/2020 - 06/2018
3	Alveolar Bone Loss 05/2009 - 05/2005
2	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 01/2022
2	COVID-19 03/2022 - 08/2020
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
2	Weight Loss (Weight Reduction) 01/2022 - 01/2021
2	Atherosclerosis 01/2022 - 08/2010
2	Nasopharyngeal Carcinoma 01/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 10/2020 - 08/2020
2	Hyperglycemia 02/2020 - 07/2019
2	Type 2 Diabetes Mellitus (MODY) 02/2020 - 04/2019
2	Insulin Resistance 02/2020 - 01/2020
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2020 - 10/2019
2	Neuralgia (Stump Neuralgia) 06/2018 - 06/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 10/2011
2	Hemorrhage 01/2013 - 06/2010
1	Pathologic Processes 06/2022
1	Acute Cholecystitis 04/2022
1	Cerebral Infarction 01/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2022
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2021
1	Nervous System Trauma 12/2021
1	Thrombosis (Thrombus) 09/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2021
1	Animal Diseases 05/2021
1	Myocardial Infarction 04/2021
1	Neuroinflammatory Diseases 02/2021
1	Anxiety Disorders (Anxiety Disorder) 02/2021
1	Schizophrenia (Dementia Praecox) 02/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Body-Weight Trajectory 01/2021

Drug/Important Bio-Agent (IBA)

8	Inulin FDA Link 01/2022 - 01/2019
7	Proteins (Proteins, Gene)FDA Link 06/2022 - 06/2018
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
4	LipopolysaccharidesIBA 04/2022 - 01/2019
4	Linseed Oil (Flaxseed Oil)IBA 01/2022 - 02/2017
4	LipidsIBA 01/2022 - 04/2019
4	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 01/2010
3	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2022 - 01/2020
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 01/2020
3	Messenger RNA (mRNA)IBA 10/2020 - 01/2011
3	CytokinesIBA 08/2020 - 05/2009
3	Interleukin-10 (Interleukin 10)IBA 03/2020 - 08/2006
3	InterleukinsIBA 01/2020 - 01/2019
2	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 01/2022
2	Long Noncoding RNAIBA 01/2022 - 05/2019
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 08/2006
2	Circular RNAIBA 12/2021 - 01/2020
2	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2020
2	StreptavidinIBA 08/2020 - 09/2004
2	Testosterone (Sustanon)FDA Link 01/2020 - 10/2019
2	MetalsIBA 11/2019 - 03/2015
2	FlavonoidsIBA 08/2019 - 08/2010
2	AntioxidantsIBA 08/2019 - 08/2010
2	PrebioticsIBA 04/2019 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 01/2019
2	Virulence Factors (Pathogenicity Factors)IBA 02/2016 - 02/2005
2	danhongIBA 01/2016 - 01/2015
2	PhosphopeptidesIBA 03/2015 - 10/2013
2	Bevacizumab (Avastin)FDA Link 01/2011 - 12/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 09/2004
1	Immune Checkpoint ProteinsIBA 04/2022
1	6-methyladenineIBA 04/2022
1	Indicators and Reagents (Reagents)IBA 04/2022
1	MicroplasticsIBA 04/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 01/2022
1	Sulfhydryl Compounds (Thiols)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 12/2021
1	Molecular Chaperones (Chaperone, Molecular)IBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2021
1	Tetracycline (Achromycin)FDA LinkGeneric 05/2021
1	IvabradineIBA 04/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2021
1	LuteolinIBA 01/2021

Therapy/Procedure

10	Therapeutics 04/2022 - 12/2010
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2010
3	Radiotherapy 01/2022 - 10/2007
3	Catheters 09/2021 - 01/2018
2	Quantum Dots (Quantum Dot) 08/2020 - 04/2019
2	Length of Stay 01/2019 - 01/2013
1	Immunotherapy 01/2021